Oppenheimer Downgrades Somaxon Pharmaceuticals To Perform, Removes PT

Symbols: SOMX
Share

Oppenheimer has downgraded Somaxon Pharmaceuticals (NASDAQ: SOMX) from Outperform to Perform and has removed its $6 price target.


 
 
< Previous
UPDATE: Benchmark Upgrades Sunoco To Hold
Next >
Benzinga's Top Upgrades
Share
Printer-friendly version
Send to friend
We're Loving

Benzinga's Premium Memberships

Benzinga's News Delivered Free

Brain Trust